Cell salvage in obstetrics

International Journal of Obstetric Anesthesia

Volumn 17, Issue 1, 2008, Pages 37-45

  Allam, J ^a   Cox, M ^a   Yentis, S M ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Autologous transfusion; Autotransfusion; Blood salvage; Caesarean section; Cell salvage; Obstetric haemorrhage; Post partum haemorrhage

Indexed keywords

ALLOIMMUNIZATION; AMNION FLUID EMBOLISM; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CELL SALVAGE; CESAREAN SECTION; LEUKOCYTE; MEDLINE; OBSTETRIC HEMORRHAGE; POSTPARTUM HEMORRHAGE; REVIEW;

BLOOD TRANSFUSION, AUTOLOGOUS; EMBOLISM, AMNIOTIC FLUID; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; TREATMENT OUTCOME;

EID: 37349119739     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijoa.2007.08.001     Document Type: Review

References (102)

1. Why Mothers Die. Confidential Enquiry into Maternal and Child Health 2000-2002. London: RCOG; 2004.
2. Waterstone M., Bewley S., and Wolfe C. Incidence and predictors of severe obstetric morbidity: case control study. BMJ 322 (2001) 1089-1093
3. Catling S. Blood conservation techniques in obstetrics: a UK perspective. Int J Obstet Anesth 16 (2007) 241-249
4. Klapholz H.L. Blood transfusion in contemporary obstetric practice. Obstet Gynecol 75 (1990) 940-943
5. Chief Medical Officer. Health Service Circular. Better Blood Transfusion. Appropriate use of Blood. Department of Health, July 2002.
6. Sloan N.L., Jordan E., and Winikoff B. Effects of iron supplementation on maternal hematologic status in pregnancy. Am J Public Health 92 (2002) 288-293
7. Pena-Rosas J.P., and Viteri F.E. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev 3 (2006) CD004736
8. Vamvakas E.C. Transfusion-associated cancer recurrence and postoperative infection: Meta-analysis of randomised, controlled clinical trials. Transfusion 36 (1996) 175-186
9. McClelland D B L. Handbook of Transfusion Medicine. United Kingdom Blood Services. London: TSO; 2007: 59-62.
10. Sloand E.M., Pitt E., and Klein H.G. Safety of the blood supply. JAMA 274 (1995) 1368-1373
11. Goodnough L.T., Brecher M.E., Kanter M.H., and AuBuchon J.P. Transfusion medicine: first of two parts - blood transfusion. N Engl J Med 340 (1999) 438-447
12. Klein H.G. Immunomodulatory aspects of transfusion. Anesthesiology 91 (1999) 861-865
13. SHOT (Serious Hazards of Transfusion). www.shot-uk.org.
14. Goodnough L.T., Shander A., and Brecher M.E. Transfusion medicine: looking to the future. Lancet 361 (2003) 161-169
15. Blackbourn D.J., Ambroziak J., Lennette E., Adams M., Ramachandran B., and Levy J.A. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 349 (1997) 609-611
16. Simmonds P. Transfusion virology: progress and challenges. Blood Rev 12 (1998) 171-177
17. Llewelyn C.A., Hewitt P.E., Knight R.S.G., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
18. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., and Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon129 heterozygous patient. Lancet 364 (2004) 527-529
19. Wroe S.J., Pal S., Siddique D., et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368 (2006) 2061-2067
20. HPA (Health Protection Agency). www.hpa.org.uk.
21. Ironside J.W. Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies. Haemophilia 12 (2006) 8-15
22. Spahn D.R., and Casutt M. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology 93 (2000) 242-255
23. Goodnough L.T., Brecher M.E., Kanter M.H., and AuBuchon J.P. Transfusion medicine: second of two parts - blood conservation. N Engl J Med 340 (1999) 525-533
24. Herbert W.N.P., Owen H.G., and Collins M.L. Autologous blood storage in obstetrics. Obstet Gynecol 72 (1988) 166-170
25. McVay P.A., Hoag R.W., and Toy P.T.C.Y. Safety and use of autologous blood donation during the third trimester of pregnancy. Am J Obstet Gynecol 160 (1989) 1479-1488
26. Catling S.J., Freites O., Krishnan S., and Gibbs R. Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre. Int J Obstet Anesth 11 (2002) 128-134
27. OAA/AAGBI Guidelines for Obstetric Anaesthetic Services. Revised Edition: OAA/AAGBI; London: May 2005: 25.
28. Tawes R.L. The basic concepts of an autotransfusor: the cell saver. Semin Vasc Surg 7 (1994) 93-94
29. Tawes R.L. Clinical application of autotransfusion. Semin Vasc Surg 7 (1994) 89-90
30. Booke M., Fobker M., Fingerhut D., Storm M., Mortlemans Y., and Van Aken H. Fat elimination during intraoperative autotransfusion: An in vitro investigation. Anesth Analg 85 (1997) 959-962
31. Orr M D, Blenko J W. Autotransfusion of concentrated washed red cells from the surgical fields: a biochemical and physiological comparison of homologous cell transfusion. Proceeding of Blood Conservation Institute 1978; 116-28.
32. McShane A.J., Power C., Jackson J.F., et al. Autotransfusion: Quality of blood prepared with a red cell processing device. Br J Anaesth 59 (1987) 1035-1039
33. Serrick C.J., Scholz M., Melo A., Singh O., and Noel D. Quality of red blood cells using autotransfusion devices: a comparative analysis. J Extra Corpor Technol 35 (2003) 28-34
34. Geiger P, Platow K, Bartl A, Volk C, Junker K, Mehrkens HH. New developments in autologous transfusion systems. Anaesthesia 1998; 53 Suppl 2: 32-5.
35. Duffy G., and Tolley K. Cost analysis of autologous blood transfusion, using cell salvage, compared with allogenic blood transfusion. Transfus Med 7 (1997) 189-196
36. Huet C., Salmi L.R., Fergusson D., Koopman-van Gemert A.W., Rubens F., and Laupacis A. International Study of Perioperative Transfusion (ISPOT) Investigators: A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopaedic surgery. Anesth Analg 89 (1999) 861-869
37. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews 2006: CD001888.
38. Waters J.H., and Sprung J. Errors during intraoperative cell salvage because of inappropriate wash solutions. Anesth Analg 93 (2001) 1483-1485
39. Clarke J.M.F. Surgery in Jehovah's Witnesses. Br J Hosp Med 27 (1982) 497-500
40. Waters J.H., and Potter P.S. Cell salvage in the Jehovah's Witness patient. Anesth Analg 90 (2000) 229
41. Mattox K.L. Comparison of techniques of autotransfusion. Surgery 84 (1978) 700-702
42. Sharp W.V., Stark M., and Donovan D.L. Modern autotransfusion. Experience with a washed red cell processing technique. Am J Surg 142 (1981) 522-524
43. Linden J.V., Kaplan H.S., and Murphy M.T. Fatal air embolism due to perioperative blood recovery. Anesth Analg 84 (1997) 422-426
44. Schwieger I.M., Gallagher C.J., Finlayson D.C., et al. Incidence of cell-saver contamination during cardiopulmonary bypass. Ann Thorac Surg 48 (1989) 51-53
45. Connall T.P., Zhang J., Vaziri N.D., et al. Leukocyte CD11b and CD18 expression are increased in blood salvaged for autotransfusion. Am Surg 60 (1994) 797-800
46. Sieunarine K., Lawrence-Brown M.M., Goodman M.A., et al. Plasma levels of the lipid mediators, leukotriene B4 and lyso platelet-activating factor, in intraoperative salvaged blood. Vox Sang 63 (1992) 168-171
47. Bull S., and Bull M.H. The salvaged blood syndrome: a sequel to mechanochemical activation of platelets and leukocytes?. Blood Cells Mol Dis 16 (1990) 215-223
48. Tawes R.L., and Duvall T.B. Is the "salvaged-cell syndrome" myth or reality?. Am J Surg 172 (1996) 172-174
49. Innerhofer P., Wiedermann F., Tiefenthaler W., et al. Are leukocytes in salvaged washed autologous blood harmful for the recipient? The results of a pilot study. Anesth Analg 93 (2001) 566-572
50. Steiner P.E., and Lushbaugh C.C. Maternal pulmonary embolism by amniotic fluid as a cause of obstetric shock and unexpected deaths in obstetrics. JAMA 117 (1941) 1245 and 1340
51. Morgan M. Amniotic fluid embolism. Anaesthesia 34 (1979) 20-32
52. Tufnell D.J. United Kingdom amniotic fluid embolism register. Br J Obstet Gynaecol 112 (2005) 1625-1629
53. nd ed. (1964), Churchill, London 48
54. Halmagyi D.F.J., Starzecki B., and Shearman R.P. Experimental amniotic fluid embolism: mechanism and treatment. Am J Obstet Gynecol 84 (1962) 251
55. Attwood H.D., and Downing S.E. Experimental amniotic fluid and meconium embolism. Surg Gynecol Obstet 120 (1965) 255
56. Clark S.L., Hankins D.V., Dudley D.A., Dildy G.A., and Porter T.F. Amniotic fluid embolism: analysis of the National Registry. Am J Obstet Gynecol 172 (1995) 1158-1169
57. Clarke S.L., Pavlova A., Greenspoon J., Horenstein J., and Phelan J.P. Squamous cells in the maternal pulmonary circulation. Am J Obstet Gynecol 154 (1986) 104-106
58. Kuhlman K., Hidvegi D., Tamura R.K., et al. Is amniotic fluid material in the central circulation of peripartum patients pathologic?. Am J Perinatol 2 (1985) 295-299
59. Yentis S.M. Sudden obstetric collapse syndrome. Int J Obstet Anesth 8 (1999) 296
60. Zichella L., and Gramolini R. Autotransfusion during cesarean section. Am J Obstet Gynecol 162 (1990) 295
61. Thornhill M.L., O'Leary A.J., Lussos S.A., Rutherford C., and Johnson M.D. An in-vitro assessment of amniotic fluid removal from human blood through cell saver processing. Anesthesiology 75 (1991) A830
62. Fong J., Gurewitcsh E.D., Kump L., and Klein R. Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol 93 (1999) 968-972
63. Lockwood C.J., Bach R., Guha A., et al. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 165 (1991) 1335-1341
64. Fuhrer Y., Bayoumeu F., Boileau S., Dousset B., Foliguet B., and Laxenaire M.C. Evaluation of the blood quality collected by cell-saver during cesarean section. Ann Fr Anesth Reanim 15 (1996) 1162-1167
65. Bernstein H.H., Rosenblatt M.A., Gettes M., and Lockwood C. The ability of the Haemonetics 4 Cell Saver System to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg 85 (1997) 831-833
66. Henn-Beilharz C., and Krier C. Re-transfusion in bone surgery: what happens to the fat?. Anaesthesiol Intensivmed Notfallmed Schmerzther 26 (1991) 224-225
67. Dzik S. Leukodepletion blood filters: Filter design and mechanisms of leukocyte removal. Transfus Med Rev 7 (1993) 65-77
68. Edelman M.J., Potter P., Mahaffey K.G., Frink R., and Leidich R.B. The potential for reintroduction of tumor cells during intraoperative blood salvage: Reduction of risk with use of the RC-400 leukocyte depletion filter. Urology 47 (1996) 179-181
69. Kongsgaard U.E., Wang M.Y., and Kvalheim G. Leucocyte depletion filter removes cancer cells in human blood. Acta Anaesthesiol Scand 40 (1996) 118-120
70. Thomas M.J.G. Infected and malignant fields are an absolute contraindication to intraoperative cell salvage: fact or fiction?. Transfus Med 9 (1999) 269-278
71. Ezzedine H., Baele P., and Robert A. Bacteriologic quality of operative autotransfusion. Surgery 109 (1991) 259-264
72. Ozmen V., McSwain N.E., Nichols R.L., Smith J., and Flint L.M. Autotransfusion of potentially culture-positive blood (CPB) in abdominal trauma: preliminary data from a prospective study. J Trauma 32 (1992) 36-39
73. Rainaldi M.P., Tazzari P.L., Scagliarini G., Borghi B., and Conte R. Blood salvage during caesarean section. Br J Anaesth 80 (1998) 195-198
74. Durand F., Duchesne-Gueguen M., Le Bervet J.Y., et al. Rheologic and cytologic study of autologous blood collected with Cell Saver 4 during caesarean. Rev Fr Transfus Hemobiol 32 (1989) 179-191
75. Waters J.H., Biscotti C., Potter P.S., and Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 92 (2000) 1519-1522
76. Munoz-Gomez M, Romero Ruiz A, Ariza Villanueva D, et al. [Ability of leukocyte reduction filters to remove fat particles from blood in experimental models simulating blood salvage in orthopedic surgery]. Rev Esp Anestesiol Reanim 2005; 52: 81-7.
77. Catling S.J., Williams S., and Fielding A.M. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth 8 (1999) 79-84
78. Papageorgiades G. Transplacental passage of fetal red cells into the maternal circulation. In normal, abnormal, and instrumental deliveries. Clin Pediatr (Phila) 15 (1976) 42-43
79. Lostumbo M.M., Holland P.V., and Schmidt P.J. Isoimmunisation after multiple transfusions. N Engl J Med 275 (1966) 141-144
80. Cunningham F.G., MacDonald P.C., Gant N.F., et al. Diseases and injuries of the fetus and newborn. 20th ed. Williams Obstetrics (1997), Appleton and Lange, Stamford 967-1008
81. Freischlag J.A. Intraoperative blood salvage in vascular surgery - worth the effort?. Crit Care 8 (2004) S53-S56
82. Alvarez G.G., Fergusson D.A., Neilipovitz D.T., and Hebert P.C. Cell salvage does not minimize perioperative allogeneic blood transfusion in abdominal vascular surgery: a systematic review. Can J Anesth 51 (2004) 425-431
83. Keeling M.M., Gray L.A., Brink M.A., Hillerick V.K., and Bland K.I. Intraoperative autotransfusion: Experience in 725 consecutive cases. Ann Surg 197 (1983) 536-541
84. Merrill B.S., Mitts D.L., Rogers W., and Weinberg P.C. Autotransfusion intraoperative use in ruptured ectopic pregnancy. J Reprod Med 24 (1980) 14-16
85. Yamada T., Okamoto Y., Kasamatsu H., and Mori H. Intraoperative autologous blood transfusion for hemoperitoneum resulting from ectopic pregnancy or ovarian bleeding during laparoscopic surgery. J Soc Laparoendosc Surg 7 (2003) 97-100
86. Catling S., and Joels L. Cell salvage in obstetrics: the time has come. Br J Obstet Gynaecol 112 (2005) 131-132
87. Jackson S.H., and Lonser R.E. Safety and effectiveness of intracesarean blood salvage. Transfusion 33 (1993) 181
88. Rebarber A., Lonser R., Jackson S., Copel J.A., and Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 179 (1998) 715-720
89. O'Brien J.M., Barton J.R., and Donaldson E.S. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 175 (1996) 1632-1638
90. Potter P.S., Waters J.H., Burger G.A., and Mraovic B. Application of cell salvage during cesarean section. Anesthesiology 90 (1999) 619-621
91. de Souza A., Permezel M., Anderson M., Ross A., McMillan J., and Walker S. Antenatal erythropoietin and intra-operative cell salvage in a Jehovah's Witness with placenta praevia. Br J Obstet Gynaecol 110 (2003) 524-526
92. Oei S.G., Wingen C.B.M., and Kerkkamp H.E.M. Cell salvage: how safe in obstetrics?. Int J Obstet Anesth 9 (2000) 143
93. Grimes D.A. A simplified device for intraoperative autotransfusion. Obstet Gynecol 72 (1988) 947-950
94. Waters J.H., Lukauskiene E., and Anderson M.E. Intraoperative blood salvage during cesarean delivery in a patient with beta thalassemia intermedia. Anesth Analg 97 (2003) 1808-1809
95. Boonstra J.G., Overbeeke M.A., de Rijke Y.B., and Duvekot J.J. A pregnant woman with irregular erythrocyte antibodies for whom no compatible packed red blood cells were available. Ned Tijdschr Geneeskd 149 (2005) 2613-2618
96. ACOG Committee opinion. Placenta accreta. Number 266, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 2002; 77: 77-78.
97. National Institute for Health and Clinical Excellence. Intraoperative blood cell salvage in obstetrics. Interventional Procedure Guidance 144. November 2005, 1.1-2.4.3.
98. Weiskopf R.B. Erythrocyte salvage during cesarean section. Anesthesiology 92 (2000) 1519-1522
99. Camann W. Cell salvage during cesarean delivery: is it safe and valuable? Maybe, maybe not!. Int J Obstet Anesth 8 (1999) 75-76
100. Waters JH (proposer), Santrach PJ (opposer). Is cell salvage a safe technique for the obstetric patient? Society for Obstetric Anesthesia and Perinatology (SOAP) Newsletter, Fall 2005: 7-9.
101. Thomas D (proposer), Clark V (opposer). Facilities for blood salvage (cell saver technique) must be available in every obstetric theatre. Int J Obstet Anesth 2005; 14: 48-52.
102. McCheyne J., Arfeen Z., Evans P., and Misra U. Massive obstetric haemorrhage: a survey of obstetric units in the UK. Int J Obstet Anesth 14 (2005) S6